Literature DB >> 580172

Concurrence of Grave's disease and Hashimoto's thyroiditis.

T Sato, I Takata, T Taketani, K Saida, H Nakajima.   

Abstract

Early histological changes in the thyroid gland were examined in 30 patients with juvenile thyrotoxicosis, by means of needle biopsy. Based on the degree of lymphocytic infiltration and degenerative changes in follicular epithelium, results were classified into four groups. A: hyperplastic changes without cellular infiltration (6 patients, 20%); B: hyperplastic changes with areas of focal thyroiditis less than 30% of specimen (10 patients, 33%); C: those with 30 to 60% areas ot thyroiditis (10 patients, 33%); D: almost diffuse thyroiditis (4 patients, 13%). Moderate to severe lymphocytic thyroiditis was frequently present in the early stage of hyperplastic thyroid glands. The clinical significance of the 4 histological groups was evaluated. Neither clinical signs nor routine laboratory tests could differentiate these groups except group D, in which thyrotoxic signs were mild and transient. However, serum antithyroid antibodies tended to increase in accordance with severity of thyroiditis. The rate of remission was high in groups C and D, whereas relapse was frequent in group A. These results suggest that Grave's disease and chronic lymphocytic thyroiditis are closely related in the early stage of thyrotoxicosis in children, and that the clinical course may be considerably altered by the degree of associated thyroiditis.

Entities:  

Mesh:

Year:  1977        PMID: 580172      PMCID: PMC1545047          DOI: 10.1136/adc.52.12.951

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Hyperthyroidism in children: observations in 50 treated cases, including an evaluation of endocrine factors.

Authors:  J C MCCLINTOCK; T F FRAWLEY; J H HOLDEN
Journal:  J Clin Endocrinol Metab       Date:  1956-01       Impact factor: 5.958

Review 2.  The pathogenesis of Graves' disease and Hashimoto's thyroiditis.

Authors:  R Volpé; N R Farid; C Von Westarp; V V Row
Journal:  Clin Endocrinol (Oxf)       Date:  1974-07       Impact factor: 3.478

3.  LATS production by lymphocyte culture in patients with Graves' disease.

Authors:  K Miyai; M Fukuchi; Y Kumahara; H Abe
Journal:  J Clin Endocrinol Metab       Date:  1967-06       Impact factor: 5.958

4.  Late thyrotoxicosis complicating autoimmune thyroiditis.

Authors:  I Gavras; J A Thomson
Journal:  Acta Endocrinol (Copenh)       Date:  1972-01

Review 5.  Current concepts in management of thyroid disease.

Authors:  L J DeGroot
Journal:  Med Clin North Am       Date:  1970-01       Impact factor: 5.456

6.  Direct evidence for human thyroidal stimulation by LATS-protector.

Authors:  Y Shishiba; T Shimizu; S Yoshimura; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1973-03       Impact factor: 5.958

7.  The pathogenesis of Graves' disease. A disorder of delayed hypersensitivity?

Authors:  R Volpe; M Edmonds; L Lamki; P V Clarke; V V Row
Journal:  Mayo Clin Proc       Date:  1972-11       Impact factor: 7.616

8.  Hyperthyroidism associated with histologic Hashimoto's thyroiditis.

Authors:  V Fatourechi; W M McConahey; L B Woolner
Journal:  Mayo Clin Proc       Date:  1971-10       Impact factor: 7.616

9.  Demonstration of the production of the long acting thyroid stimulator (LATS) by peripheral lymphocytes cultured in vitro.

Authors:  J R Wall; B F Good; I J Forbes; B S Hetzel
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

10.  New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.

Authors:  T Onaya; M Kotani; T Yamada; Y Ochi
Journal:  J Clin Endocrinol Metab       Date:  1973-05       Impact factor: 5.958

View more
  5 in total

1.  Effects of low-dose-gamma rays on the immune system of different animal models of disease.

Authors:  Noriko Shimura; Shuji Kojima
Journal:  Dose Response       Date:  2014-04-23       Impact factor: 2.658

2.  Thyroid peroxidase autoantibodies are associated with a lesser likelihood of late reversion to hyperthyroidism after successful non-ablative treatment of Graves' disease in Croatian patients.

Authors:  M Stefanic; I Karner
Journal:  J Endocrinol Invest       Date:  2014-01-08       Impact factor: 4.256

3.  Propylthiouracil and hepatitis: a case report.

Authors:  C M Reddy
Journal:  J Natl Med Assoc       Date:  1979-12       Impact factor: 1.798

Review 4.  Antithyroid Drug Therapy for Graves' Disease and Implications for Recurrence.

Authors:  Jia Liu; Jing Fu; Yuan Xu; Guang Wang
Journal:  Int J Endocrinol       Date:  2017-04-25       Impact factor: 3.257

5.  A case of Hashimoto's thyroiditis following Graves' disease.

Authors:  Ibtissem Oueslati; Salma Salhi; Meriem Yazidi; Fatma Chaker; Melika Chihaoui
Journal:  Clin Case Rep       Date:  2022-10-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.